Model | Riley’s sample size | 10 EPP | 5 EPP | Riley’s EPP |
---|---|---|---|---|
NB 5-year mortality risk | 1111 | 978 | 490 | 11.37 |
NB relapse/progression risk | 1168 | 1166 | 584 | 10.03 |
NB time to death | 1397 | 978 | 490 | 7.00 |
HR-NB 5-year mortality risk | 1043 | 600 | 300 | 17.38 |
HR-NB 5-year relapse/progression risk | 1060 | 736 | 369 | 14.42 |
HR-NB time to relapse/progression | 1060 | 536 | 268 | 11.23 |
DIPG 1-year mortality risk | 1043 | 668 | 334 | 15.65 |
DIPG 2-year mortality risk | 1345 | 1776 | 889 | 7.58 |
DIPG 1-year progression risk | 1208 | 1278 | 639 | 9.46 |
DIPG time to death | 1273 | 1776 | 889 | 7.87 |
DIPG time to progression | 1130 | 1278 | 639 | 9.67 |